SciELO - Scientific Electronic Library Online

 
vol.17 suppl.3VEGF immunoexpression in penile carcinomaTreatment of hydrocephalus by ventriculoperitoneal shunt: analysis of 150 consecutive cases in the Hospital of the Faculty of Medicine of Ribeirão Preto author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Acta Cirúrgica Brasileira

Print version ISSN 0102-8650On-line version ISSN 1678-2674

Abstract

DIAS NETO, José Anastácio et al. Outcome of germ cell tumors. Acta Cir. Bras. [online]. 2002, vol.17, suppl.3, pp.55-58. ISSN 1678-2674.  https://doi.org/10.1590/S0102-86502002000900012.

OBJECTIVE: The aim of the study is to analyze the characteristics and the evolution of patients with testicular germ cell tumors. METHODS: We analyzed 29 patients: 14 seminomas and 15 non-seminomas. All of them underwent orquiectomy. Patients with seminomas stage II and III received adjuvant treatment with raditherapy, and those with non-seminomas stage II and III received neoadjuvant chemotherapy followed by lymphadenectomy. Mean followup for seminomas was 56 months and for non-seminomas it was 40 months. RESULTS: The most common complain was an increase in testis volume (57%) and pain (30%). The mean age in seminomas was 41.2 years and in non-seminomas it was 29.2 years. Previous criptorquidy was refered by 28.5% of patients with seminomas and 15.5% with non-seminomas. The respective proportions of stages I, II and III were 79%, 14% and 7% in seminomas, and 40%, 27% and 33% in non-seminomas. Patients with seminomas did not show serum rise of alfa-fetoprotein or b-HCG while those with non-seminomas such tumor markes were elevated respectively in 46.6% and 33.3% of the sample. Disease specific death occurred in 1 patient with seminoma and in 3 with non-seminoma tumor, but survival curves were similar for both groups. CONCLUSION: In spite of the earlier treatment of criptorquidy such an antecedent stand as an important risk factor for the development of testicular germ cell tumor. Even though non-seminomas presents with higher stages the survival curves are similar for both groups of tumors. Analyze 29 patients that were submitted to orquiectomy (14 seminomas e 15 non seminomas), concerning their age, signs and symptoms, risk factors, clinical staging, tumor markers follow up and survival rates. RESULTS: There was no statistically difference in survival rates of patients with seminomas and non-seminomas tumors.

Keywords : testicular tumor; seminoma; non-seminoma; germ cell tumor.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License